Confined or spread disease-Spread beyond the prostate gland-Invades nearby organs Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread beyond the prostate gland-Invades nearby organs Posts on Medivizor

Comparing outcome in robotic-assisted versus laparoscopic prostate surgery

Comparing outcome in robotic-assisted versus laparoscopic prostate surgery

Posted by on Mar 10, 2021 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness of functional and oncological outcomes of robotic-assisted (RA) and laparoscopic (Lap) radical prostatectomy (RP; removal of the prostate) in localized and locally advanced prostate cancer (PCa). the study concluded that RARP was similarly effective and had better urinary and sexual outcomes...

Read More

Reviewing treatment options for patients with high-risk prostate cancer

Reviewing treatment options for patients with high-risk prostate cancer

Posted by on Mar 19, 2020 in Prostate cancer | 0 comments

In a nutshell This article reviewed treatment options for patients with high-risk prostate cancer. Some background Prostate cancer is a cancer that starts in the prostate gland. There are different types of treatment for patients with prostate cancer. Treatment choice depends on disease stage or whether the cancer has spread to other parts of the...

Read More

The role of androgen deprivation therapy plus radiotherapy in the treatment of prostate cancer after prostate surgery

The role of androgen deprivation therapy plus radiotherapy in the treatment of prostate cancer after prostate surgery

Posted by on Jan 12, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared the safety and effectiveness of short-term androgen deprivation therapy (ADT) combined with radiotherapy (RT) in patients who underwent radical prostatectomy (RP). The main finding was that the combination of ADT and RT reduced the risk of recurrence and disease progression in these patients. Some background RP is...

Read More

Looking for patients with high-risk prostate cancer to test a combination therapy

Looking for patients with high-risk prostate cancer to test a combination therapy

Posted by on Aug 31, 2019 in Prostate cancer | 0 comments

In a nutshell This study aims to examine the effectiveness of niraparib (Zejula) combined with hormone therapy and radiotherapy to treat patients with high-risk prostate cancer. The main outcome to be measured will be how long patients remain cancer-free. This study is recruiting in Philadelphia, PA. The details Prostate cancer occurs mostly...

Read More

Risk of treatment related toxicity from radiation therapy on prostate and lymph nodes vs prostate and prostate only

Risk of treatment related toxicity from radiation therapy on prostate and lymph nodes vs prostate and prostate only

Posted by on Jun 30, 2019 in Prostate cancer | 0 comments

In a nutshell This article investigated the toxicity of intensity-modulated radiation therapy (IMRT) to the prostate and pelvic lymph nodes (PPLN-IMRT) compared with prostate-only (PO-IMRT) in high-risk prostate cancer (PC).  The authors concluded that both treatments had similar toxicity rates in these patients. Some background...

Read More

Long term results discussing radiotherapy and hormone therapy treatments for patients with prostate cancer

Posted by on Dec 16, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to evaluate whole pelvic radiotherapy (WPRT) compared to prostate only radiotherapy (PORT) with hormonal therapy (HT) before or after radiation for patients with intermediate- or high-risk prostate cancer. This study found that HT before radiotherapy and WPRT had superior long-term survival without cancer growing or...

Read More

Comparing prostate surgery with radiotherapy and radiotherapy with androgen deprivation therapy for advanced prostate cancer

Posted by on Oct 28, 2018 in Prostate cancer | 0 comments

In a nutshell This study aimed to investigate the long-term effects of two treatment combinations for advanced prostate cancer. This study found that surgery and radiotherapy had improved overall survival in comparison with radiotherapy plus androgen deprivation therapy (ADT) in these patients, but with higher rates of side-effects. Some background...

Read More

Can PSA level indicate either cure or the need for long term hormone suppression treatment?

Can PSA level indicate either cure or the need for long term hormone suppression treatment?

Posted by on Jan 12, 2015 in Prostate cancer | 1 comment

In a nutshell This study investigated if measuring the levels of prostate specific antigen (PSA) after cancer therapy could indicate a cure or if the patient should be considered for long term androgen deprivation (suppression) therapy. The main finding was that lower PSA blood levels predict better survival in patients with prostate cancer. Some...

Read More

Therapies for recurrence after radiotherapy

Therapies for recurrence after radiotherapy

Posted by on Dec 10, 2013 in Prostate cancer | 0 comments

In a nutshell This review evaluated the safety and efficacy of focal salvage ablative therapy for the treatment of patients with prostate cancer recurrence (return of the cancer) after radiation therapy. Some background Radiation therapy (RT) is often used to treat early stage prostate cancer. However, after RT, the cancer may recur, locally...

Read More

Treatment options for prostate cancer recurrence

Treatment options for prostate cancer recurrence

Posted by on Nov 28, 2013 in Prostate cancer | 0 comments

In a nutshell This review investigated treatment options following biochemical recurrence after primary treatment for prostate cancer. Some background Prostate cancer can be treated using a variety of methods, the most common being partial or full removal of the prostate gland, a procedure known as a prostatectomy. Other treatments include...

Read More